FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SKNV | 080105003 | 72934-2590 | 72934-2590-2 | Dapsone; Niacinamide; Spironolactone | 8.5 g/100 g; 2 g/100 g; 5 g/100 g | 2026-1 | valid | 2026-10-06 | |
| SKNV | 72934-2590 | 72934-2590-2 | Admirazol | 011557 DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5% | 8.5 g/100 g; 2 g/100 g; 5 g/100 g | 2026-1 | valid | 2026-09-18 | |
| SKNV | 080105003 | 72934-2590 | 72934-2590-2 | Spironolactone; Dapsone; Niacinamide | 5 g/100 g; 8.5 g/100 g; 2 g/100 g | 2025-2 | valid | 2026-10-06 | |
| SKNV | 72934-2590 | 72934-2590-2 | Admirazol | 011557 DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5% | 5 g/100 g; 8.5 g/100 g; 2 g/100 g | 2025-2 | valid | 2026-09-18 | |
| SKNV | 080105003 | 72934-2590 | 72934-2590-2 | Spironolactone; Dapsone; Niacinamide | 5 g/100 g; 8.5 g/100 g; 2 g/100 g | 2025-1 | valid | 2026-10-06 | |
| SKNV | 72934-2590 | 72934-2590-2 | Admirazol | 011557 DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5% | 5 g/100 g; 8.5 g/100 g; 2 g/100 g | 2025-1 | valid | 2026-09-18 |